A Three-Part Intervention To Change the Use of Hormone Replacement Therapy in Response to New Evidence

  1. Christianne L. Roumie, MD;
  2. Eric L. Grogan, MD;
  3. William Falbe, PharmD;
  4. Joseph Awad, MD;
  5. Theodore Speroff, PhD;
  6. Robert S. Dittus, MD, MPH; and
  7. Tom A. Elasy, MD, MPH
  1. From Veterans Administration Tennessee Valley Healthcare System and Vanderbilt University, Nashville, Tennessee.
    1. Figure 1. ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center.
      View larger version:
        Figure 1. ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center. Study timeline.
      • Figure 2. Hazard ratio, 4.9 (95% CI, 1.8 to 13.1). ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center.
        View larger version:
          Figure 2. Hazard ratio, 4.9 (95% CI, 1.8 to 13.1). ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center. Discontinuation of hormone replacement therapy (HRT).
        • Appendix Figure 1.
          View larger version:
            Appendix Figure 1. Provider education e-mail.
          • Appendix Figure 2.
            View larger version:
              Appendix Figure 2. Patient education letter.
            • Appendix Figure 3.
              View larger version:
                Appendix Figure 3. Pharmacy alert.

              Summary for Patients

              « Previous | Next Article »Table of Contents